![ECOG-ACRIN logo[19516]275×75](https://blog-ecog-acrin.org/wp-content/uploads/2021/03/ECOG-ACRIN-logo19516275x75.png)
May 28, 2026
A recap of the Spring 2026 Group Meeting and reflections on addressing distrust in science
May 28, 2026
Dr. Anagnostou is honored as a world-renowned lung cancer translational research investigator
May 28, 2026
The group is recognizing Dr. Berlin for his sustained commitment to mentoring early- and mid-career investigators in cancer medicine
May 28, 2026
ACHIEVE is the first lung cancer clinical trial for older patients with metastatic NSCLC, comparing immunotherapy (pembrolizumab) with and without chemotherapy
May 28, 2026
The latest findings in breast cancer, cardiotoxicity, leukemia in older adults, and reproductive health management for cancer patients of childbearing age
May 28, 2026
Timely information about research presented at medical meetings, recognition of research leaders, and more
May 20, 2026
This phase 3 clinical trial is comparing aromatase inhibitors and ribociclib, with and without chemotherapy, to prevent recurrence